Latest Period
Q1 2026
Security Snapshot
Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO) Institutional Ownership
CUSIP: 82711P201
13F Institutional Holders and Ownership History from Q3 2022 to Q1 2026
Institutions Reporting
14
Shares (Excl. Options)
1,055,805
Price
$0.36
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common stock, par value $0.0001 per share
- Symbol
- SILO on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,055,805
- Total 13F value
- $379,779
- Portfolio coverage rank
- 0%
- Share change
- -157,834
- Value change
- -$49,381
- Number of holders
- 14
- Shares outstanding
- 14,275,224
- SEC-reported price per share
- $0.40
- Insider filing price
- $0.40
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- SILO - Silo Pharma, Inc. - Common stock, par value $0.0001 per share is tracked under CUSIP 82711P201.
- 14 institutions reported positions in Q1 2026.
- 3 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 15 to 14 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $412,372 to $379,779.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 14 institutions filings for Q1 2026.
Security key
82711P201
Latest holder period
Q1 2026
13F holders
14
13D/G owners
3
CIK / CUSIP context first
Open Q1 2026 holders
SILO full holder history
Silo Pharma, Inc. SEC filings
Silo Pharma, Inc. company facts
Silo Pharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 82711P201:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
3
Security
SILO
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| INTRACOASTAL CAPITAL, LLC | 10% | 0% | $561,702 | +$35,627 | 1,478,164 | +6.8% | Mitchell P. Kopin | 31 Dec 2025 |
| Anson Funds Management LP | 4.9% | -33% | $265,805 | -$96,100 | 699,486 | -27% | Anson Funds Management LP | 31 Dec 2025 |
| RENAISSANCE TECHNOLOGIES LLC | 0.84% | -84% | $30,375 | -$153,500 | 37,500 | -83% | Renaissance Technologies LLC | 31 Dec 2024 |
As of 31 Mar 2026, 14 institutional investors reported holding 1,055,805 shares of Silo Pharma, Inc. - Common stock, par value $0.0001 per share (SILO). This represents 7.4% of the company’s total 14,275,224 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
15
Latest
Q1 2026
Rows shown
1-15 of 15
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,055,805 | $379,779 | -$49,381 | $0.36 | 14 |
| 2025 Q4 | 1,213,639 | $412,372 | -$457,238 | $0.34 | 15 |
| 2025 Q3 | 1,551,022 | $1,069,833 | +$795,693 | $0.69 | 14 |
| 2025 Q2 | 406,814 | $256,292 | +$89,070 | $0.63 | 13 |
| 2025 Q1 | 247,864 | $285,030 | +$101,430 | $1.17 | 12 |
| 2024 Q4 | 182,551 | $161,999 | -$141,059 | $0.89 | 14 |
| 2024 Q3 | 337,799 | $371,282 | +$242,634 | $1.10 | 12 |
| 2024 Q2 | 119,574 | $117,878 | +$5,461 | $1.00 | 10 |
| 2024 Q1 | 112,818 | $219,125 | -$86,729 | $1.95 | 10 |
| 2023 Q4 | 160,652 | $231,338 | +$79,313 | $1.44 | 10 |
| 2023 Q3 | 105,573 | $175,734 | +$9,904 | $1.67 | 8 |
| 2023 Q2 | 99,698 | $203,640 | +$25,715 | $2.05 | 7 |
| 2023 Q1 | 87,154 | $183,307 | +$131,422 | $2.10 | 6 |
| 2022 Q4 | 21,483 | $72,276 | -$186,568 | $3.37 | 6 |
| 2022 Q3 | 50,673 | $273,000 | +$273,000 | $5.41 | 3 |